SciCom is delighted to announce that it will co-organise two high-profile symposia at AAAS 2016 titled: “Neuroscience Clues To The Chemistry of Addictions & Mood Disorders” & “Statecraft & Scalpel: Regional & Global Health Diplomacy in 2016 And Beyond”.
EuroScience teamed up with GB member Aidan Gilligan’s SciCom, Julian Kinderlerer, the chair of the European Group on Ethics, and Michel Kazatchkine, UN SG Ban Ki-moon’s special Envoy on HIV/AAIDS for Central Asia and East and Central Europe for a high-level reception and dinner in Brussels on June 17, 2015. For EuroScience this was an opportunity to celebrate our partnership with Johnson&Johnson and five European Foundations. The picture shows Dr. Frederik Wittock and Dr. Ludo Lauwers from J&J, and Treasurer Tony Mayer and Secretary General Peter Tindemans.
The Japan Science and Technology Agency (JST) has appointed SciCom – Making Sense of Science as its Strategic International Engagement Adviser.
SciCom – Making Sense of Science has partnered with organisers of the world’s top science events to create a new grouping titled “Forum of Global Fora” which was launched at a VIP Reception on 13th February, 2015 at the Annual Meeting of the American Association for the Advancement of Science in San José, California: https://aaas.confex.com/aaas/2015/webprogram/Session10302.html
By Leigh Cooper
SAN JOSE, California — Science has firmly labeled tobacco products hazardous to human health, but the consequences of using e-cigarettes are still hazy. While the popularity of these battery-powered devices that produce nicotine vapor explodes, scientists are hurrying to gather data on the use of e-cigarettes and their health effects. Meanwhile, e-cigarette companies and consumers are waiting for governments to create regulations using the limited science that is available.
"E-cigarettes show tremendous promise as a tool for helping confirmed smokers that don't respond to other approaches to quitting smoking," said Wilson Compton, deputy director of the National Institute on Drug Abuse during a 13 February press conference on the health effects of e-cigarettes at the AAAS Annual Meeting. "But for non-smokers and particularly adolescent non-smokers, e-cigarettes are not without some risks and concerns."
(Embargoed until 12:00 p.m., 02/13 US Pacific Standard time)
American Association for the Advancement of Science (AAAS) Annual Meeting,
San José, California, 13th February 2015: http://tinyurl.com/ovb93pf
Electronic cigarettes could be one of the biggest public health opportunities of our time, but that depends on who you talk to. They have been shown to be effective in helping smokers quit and many believe them to be much safer than cigarettes. But the debate rages on. Today at AAAS, a panel of global advocacy, ethical, policy, health, toxicology and industry experts from Germany, New Zealand, South Africa, the UK and USA debated: are electronic cigarettes killing me softly or our greatest public health opportunity?
E-cigarettes are already used by tens of millions of smokers around the world. Hundreds of versions are available online or in specialized shops. Analysts at Wells Fargo (2013) predict that sales will outstrip classical cigarettes by 2021. These battery-powered devices work by delivering aerosol (‘vapor’) containing nicotine to the user. The apparent medical advantage is that the vapor produced contains compounds in the tens to hundreds compared with the 86001 or more produced in cigarette smoke that cause life-threatening diseases.
The American Cancer Society2 estimates that:
Anne Glover stepped down recently from her role as chief scientific adviser to the European Commission President José Manuel Durão Barroso.
She told HARDtalk "I think I could have achieved very much more if people had been open to the possibilities that my role would give to the Commission."
Watch the interview on BBC iPlayer here
SciCom – Making Sense of Science is partnering with organisers of the world’s top science events to create a new grouping titled “Forum of Global Fora” which is being launched at a VIP Reception on 13th February, 2015 at the Annual Meeting of the American Association for the Advancement of Science in San José, California: https://aaas.confex.com/aaas/2015/webprogram/Session10302.html
In the city which first split the atom, created the programmable computer, and isolated graphene, Manchester has a proud association with scientific achievement, which is why Manchester is delighted to host the ESOF in July 2016.
Read more about ESOF in Manchester here: http://www.esof.eu/
Science advice is the process, structures and institutions through which governments and politicians consider science, technology and innovation information in policy- and decision- making. Across different national governments and international bodies, there are a variety of structures and institutions for scientific advice.
At its meeting of 4 November 2014 the Steering Committee of World Science Forum has agreed on the date and main theme of World Science Forum 2015. After the highly successful event of Rio de Janeiro in 2013 World Science Forum will return to Budapest on 4-7 November 2015.
Representatives of the Offices of Chief Scientific Advisers, large membership organisations, and the fields of nuclear energy, genetically modified organisms and harm reduction science in tobacco recently made a concerted plea that policy-makers better understand science engagement when communicating risk.
They also questioned the logic of hiding the scientific evidence and opinions fed-in behind some of today’s most controversial public policy issues.
These ideas were expressed at both the 2012 American Association for the Advancement of Science’s Annual Meeting (AAAS) held in Vancouver in February and the Euro Science Open Forum’s Bi-annual Meeting (ESOF) held in Dublin in July. Read the full article here
Having worked inside the EU’s scientific services for nearly ten years, it often amazed me how important legislation about the food we eat, the air we breathe or the transport we use is decided without the broader scientific inputs of those actually doing the science and ‘in the know’. The approach was too often: ‘Here is the policy we want. Find the science to support it.’
We have all heard about ‘bad science’ or ‘bad pharma’ but what is less spoken about is the impact of the ‘bad policy-maker’. Of course, science does not always have clear answers. And important factors beyond the reach of science are often involved: fear, hype, ignorance, resentment, or economic and political advantage. But the simple truth is that when it comes to substance addictions today, the lives of millions of people needlessly hang in the balance. Read the full article here
Having worked for ten years as a specialist communications contractor and direct employee at the headquarters of the European Commission’s in-house science service, the Joint Research Centre and its sister Directorate-General, Research & Innovation, I decided to try something new where I could make a real difference on the issues that concern me most. Harm reduction science is one of these. I’m no scientist or expert, but I know what the general public is interested in and want to pay their taxes for. Life and death is certainly one of them.
I had worked on EU-funded research events for years, focusing on topics ranging from mitigating natural disasters and launching hydrogen fuel testing facilities, to R&D Investment Scoreboards. You name it, we had seen it and done it – or at least claimed to have partially funded it. But had we ever made a discovery that really mattered? Were we interested in the big killers, those lifestyle-related killers that are preventable? Were we too busy testing food ladles from China or chasing pie-in-the-sky nuclear energy projects? Had we lost sight of what really mattered? I thought so, so I decided to be different. Read the full article here
An end to AIDS is only possible if we overcome the barriers of criminalisation, stigma and discrimination that remain key drivers of the epidemic. SciCom and its partners are fully committed to advancing the case for harm reduction in public health in every single action we take and partnership we enter.
We have now added some of the exclusive Press Conference videos from ESOF 2014 to our "SciCom in the Media" part of our website.These include the Press Conferences on Drugs, Drones, Ecigarettes, CERN, Mining the Moon.
You can access the videos from this link: http://www.sci-com.eu/home/index.php/press-room/scicom-in-the-media/esof-2014-videos
Professor Julian Kinderlerer (SA/UK), an expert in scientific integrity and ethics; Dr. Topher White (USA), an expert in sustainable development and conservation; and Dr. Andriy Klepikov (UKR), an expert in HIV/Aids prevention, treatment and care programmes have joined SciCom – Making Sense of Science as Associates from 1st July, 2014.
See the full list of SciCom Associates here: http://www.sci-com.eu/home/index.php/about-us/who-we-are/associates
Science-based issues are crucial to the conduct of foreign policy. Countries large and small, developed and developing, express a clear interest in implementing science diplomacy through politics. This is for the purpose of representation, cooperation, resolving disputes, improving systems, and securing the right to science for citizens and our most vulnerable populations. The same applies to global companies and institutions operating in a complex matrix of technical and relational challenges. This symposium will test this theory against the successes and failures of health diplomacy strategies around two challenging issues: global responses to HIV/Aids and harm reduction science linked to lifestyle.
Click to see the full session info here